Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment

Barbara Resnick, Ann Kolanowski, Kimberly Van Haitsma, Elizabeth Galik, Marie Boltz, Jeanette Ellis, Liza Behrens, Karen Eshraghi, Shijun Zhu

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.

Original languageEnglish (US)
Pages (from-to)59-69
Number of pages11
JournalClinical Nursing Research
Volume30
Issue number1
DOIs
StatePublished - Jan 2021

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Fingerprint Dive into the research topics of 'Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment'. Together they form a unique fingerprint.

Cite this